Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosomal binding domain 2 pseudogene 34 (HMGN2P34) is a human pseudogene locus with sequence similarity to the HMGN2 (high mobility group nucleosomal binding domain 2) gene. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but typically do not encode functional protein products due to mutations or genomic rearrangements. They may be transcribed into noncoding RNAs that can regulate their parent gene and other genes via various mechanisms, such as serving as RNA decoys or influencing chromatin structure, but specific biological functions for HMGN2P34 have not been characterized. There is no evidence for HMGN2P34 being a direct disease gene, clinical biomarker, or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 34 (HMGN2P34).